Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Articles
DOI: 10.1055/s-0040-1705271
Submitted: 02-06-2022
Published: 02-06-2022

Intervenções Nutrológicas em Pacientes Adultos Infectados pelo Vírus da Imunodeficiência Humana

Médico Anestesiologista / Especialista em Anestesiologia pela Sociedade Brasileira de Anestesiologia
HIV - AIDS nutrition micronutrients macronutrients nutritional interventions

Abstract

Patients living with HIV/AIDS are at increased nutritional risk at some stage of the disease, and require care from a multidisciplinary team. Nutrition and HIV infection are two pillars having a dependent and cyclic interaction, wherein malnutrition directly affects cellular immunity and, when this is reduced by a result of infection, can lead to malnutrition. Weight loss is considered an independent predictor of mortality in infected individuals. For patients with observed weight loss, you should aim to restore it with a multidisciplinary approach, ensuring proper nutrition, exercise and, if necessary, introduction of drugs. This review article aims to explain the relationship of the HIV virus with the nutritional status of the patient, including assessment of micro and macronutrients, and also to discuss treatment options for weight loss commonly seen in the history of the disease.

Metrics

Metrics Loading ...

References

  1. MINISTÉRIO DA SAÚDE. Programa Nacional de DST/AIDS. AIDS: Brasil. Boletim epidemiológico, Brasília: 2015.
  2. De Pee S, Semba RD. Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food Nutr Bull. 2010;(4):S313-S344.
  3. Sztam KA, Fawzi WW, Dugan C. Macronutrient supplementation and food prices in HIV treatment. J Nutr. 2010;140(1):213S-23S.
  4. Van Der Sande MA, Van Der Loeff MFS, Aveika AA, Sabally S, Togun T, Sarge-Njie R, et al. Body mass index at time of HIV diagnosis: a strong and independent predictor of survival. J Acquir Immune Defic Syndr. 2004;37:1288–94.
  5. Paton NI, Sangeetha S, Earnest A, Bellamy R. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Med. 2006;7:323-30.
  6. Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002; 31:230-236.
  7. Wheeler DA, Gibert CL, Launer CA, Muurahainen N, Elion RA, Abrams DI, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Journal Acquir Immune Defic Synd. 1998;242-48.
  8. Palenicek, J.P., Graham, N.M., He, Y.D. et al, Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr.1995;10:366-373.
  9. Harpstone DA, Murray CA, Ross RA, Phelan MB, Crane RC, Cozzi AD, et al. The influence of nutritional and metabolic status on progression from asymptomatic HIV infection to AIDS-defining diagnosis. AIDS. 1999;13(10):1221-6.
  10. Kotler DP, Tierney AR, Wang J, Pierson Jr RN. Magnitude of body-cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-7.
  11. Koethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, et al. Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka Zambia. J Acquir Immune Defic Syndr. 2010; 53:507-13.
  12. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817–824.
  13. Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS. 2006;20:2355–2360.
  14. Sudfeld CR, Isanaka S, Mugusi FM, Aboud S, Wang M, et al. Weight change at 1 month of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4 T cell reconstitution in a Tanzanian HIV-infected adult cohort. Am J Clin Nutr. 2013;97(6):1278-87.
  15. Beisel A. Nutrition and immune function: overview. J Nutr. 1996; 126: 2611S.
  16. Dworkin MS, Williamson JM. AIDS wasting syndrome: trends, influence on opportunistic infections, and survival. J AIDS. 2003;33:267-73.
  17. Mocroft A, Sabin CA, Youle M, Madge S, Tyrer M, Devereux H, et al. Changes in AIDS-defining illnesses in a London Clinic (1987-1998).J Acquir Immune Defic Syndr. 1999;21(5):401-7.
  18. Wanke CA, Silva M, Knox TA, et al. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;31:803-805.
  19. Tang AM, Jacobson DL, Spiegelman D, Knox TA, Wanke C. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients. J Acquir Immune Defic Syndr. 2005;40:70-6.
  20. Nerad J, Romeyn M, Silverman E, Allen-Reid J, Dieterich D, Merchant J et al. General nutrition management in patients infected with the Human Immunodeficiency Virus. Clin Infect Dis. 2003;36(2):S52–S62.
  21. Schwenk A. Bioelectrical impedance analysis in the HIV-infected patients treated with triple antiretroviral treatment. Am J Clin Nutr. 1999;70:867-873.
  22. Schwenk A, Beisenherz A, Römer K, Kremer G, Salzberger B, Elia M. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr. 2000;(72):496-501.
  23. Schwenk A, Römer K, Kremer G, Salzberger B. Clinical assessment of HIV-associated lipodystrophy syndrome: bioelectrical impedance analysis, anthropometry and clinical scores. Clin Nutr. 2001; 20(3) 243-49.
  24. Forrester JE, Spiegelman D, Tchetgen E, Knox TA, Gorbach SL. Weight loss and body-composition changes in men and women infected with HIV. AIDS. 2002;76:1428–34.
  25. Forrester JE1, Sheehan HM, Joffe TH. A validation study of body composition by bioelectrical impedance analysis in Human Immunodeficiency Virus (HIV)-positive and HIV- Negative Hispanic men and women. J Am Diet Assoc. 2008;108(3):534-538.
  26. Mulligan K, Anastos K, Justman J. Fat distribution in HIV-infected women in the United States (DEXA substudy in the Women’s Interagency HIV Study). J Acquir Immune Defic Syndr. 2005;38:18–22.
  27. Bonnet E, Delpierre C, Sommet A. Total body composition by DXA of 241 HIV negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Dens. 2005;8(3):287-92.
  28. Asha HS, Seshadri MS, Paul TV. HIV lipodystrophy: an objective definition using DXA derived regional fat ratios in a South Asian population. Endocr Pract. 2011:1-32.
  29. Grinspoon S, Mulligan K. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003;36:S69-S78.
  30. Lawn SD, Harris AD, Anglaret X, Myer L, Wood R. Early mortality among adults acessing antirretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897-908.
  31. Gupta A, Nadkarni G, Yang W-T, Chandrasekhar A, Gupte N, Bisson GP, et al. Early mortality in adults initiating ART in low and middle income countries: a systematic review and meta-analysis. PLos One. 2011: 6e28691.
  32. Malvy D, Thiebaut R, Marimotou C, Dabis F. Weight loss and body mass index as predictors of HIV disease progression to AIDS. J Am Coll Nutr. 2001;20:609-15.
  33. Madec Y, Szumilin E, Genevier C, Ferradini L, Balkan S, Pujades M, et al. Weight gain at 3 months of antirretroviral therapy is strongly associated with survival: evidence from two developing countries. AIDS. 2009;23:853-61.
  34. Koethe JR, Lukasa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, et al. Association between weight gain and clinical outcomes among malnourished adults initiating antirretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2010; 53:507-13.
  35. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med. 1995;333(2):83-8.
  36. Grobler L, Siegfried N, Visser ME, Mahlungulu SSN, Volmink J. Nutritional interventions for reducing morbidity and mortality in people with HIV. 2013. Cochrane Database of Systematic Reviews;2(2):CD004536.
  37. Olsen MF, Kaestel P, Tesfaye M, Yilma D, Girma T, Wells JCK, et al. Effects of nutritional supplementation for HIV patients starting antirretroviral treatment: randomised control trial in Ethiopia. BMJ. 2014; 348:3187.
  38. Marston B, De Cock KM. Multivitamins, nutrition, and antiretroviral therapy for HIV disease in Africa. N Engl J Med. 2004;351(1):78.
  39. Bica I, Tang AM, Skinner S, Spiegelman D, Knox T, Gorbach S, et al. Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy. J Altern Compl Med. 2003;9:65–76.
  40. Colebunders R, Dreezen C, Florence E, Pelgrom Y, Schrooten W. The use of complementary and alternative medicine by persons with HIV infection in Europe. Int J STD AIDS. 2003; 14:672–674.
  41. Beach RS, Mantero-Atienza E, Shor-Posner G, Javier JJ, Szapocznik J, Morgan R, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS. 1992;6:701–708.
  42. Kamwesiga J, Mutabazi V, Kayumba J, Tayari JC, Uwimbabazi JC, Batanage G, et al. Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial. AIDS. 2015,29:1045-52.
  43. Rule SAJ, Hooker M, Costello C, Luck W, Hoffbrand AV. Serum vitamin B12 and transcobalamin levels in early HIV disease. Am J Hematol. 1994;47:167–171.
  44. Remacha AF, Montagud M, Cadafalch J, Riera A, Martino R, Gimferrer E. Vitamin B12 transport proteins in patients with HIV-1 infection and AIDS. 1993. Haematologica;78:84–88.
  45. Tang AM, Graham NMH, Semba RD, Saah AJ. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS. 1997;11:613–620.
  46. Lacey CJ, Murphy ME, Sanderson MJ, Monteiro EF, Vail A, Schorah CJ. Antioxidant-micronutrients and HIV infection. Int J STD AIDS. 1996; 7:485–489.
  47. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998; 67:143–147.
  48. Ullrich R, Schneider T, Heise W, Schmidt W, Averdunk R, Riecken EO, et al. Serum carotene deficiency in HIV-infected patients. Berlin Diarrhoea/Wasting Syndrome Study Group. AIDS. 1994; 8:661–665.
  49. Sappey C, Leclerc P, Coudray C, Faure P, Micoud M, Favier A. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe b-carotene deficiency. Clin Chim Acta. 1994;230:35-42.
  50. Graham NMH, Sorenson D, Odaka N, Brookmeyer R, Chan D, Willett WC, et al. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr. 1991;4:976–980
  51. Tang AM, Graham NMH, Chandra RK, Saah AJ. Low serum vitamin B12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr. 1997;127:345–351.
  52. Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, Fletcher MA, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr. 1997;15:370–374.
  53. Semba RD, Caiaffa WT, Graham NMH, Cohn S, Vlahov D. Vitamin A deficiency and wasting as predictors of mortality in HIV-infected adults. J Infect Dis. 2005;171:1196-1202.
  54. Hepburn MJ, Dyal K, Runser LA, Barfield RL, Hepburn LM, Fraser SL. Low serum vitamin B12 levels in an outpatient HIV-infected population. Int J STD AIDS. 2000;15:127-133.
  55. Tang AM, Smit E, Semba RD, Shah N, Lyles CM, Li D, et al. Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2000; 23:321–326.
  56. Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr. 1993;6:949-58.
  57. Tang AM, Graham NMH, Kirby AJ, Mc- Call AD, Willett WC, Saah AJ. Dietary micrOnutrient intake and risk progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol. 1993;138:937-51.
  58. Tang AM, Lanzillotti J, Hendriks K, Gerrior J, Ghosh M, Woods M, et al. Micronutrients: current issues for HIV care providers. AIDS. 2005,19: 847-61.
  59. Lazzarotto AR, Derezs LF, Sprinz E. HIV/AIDS e treinamento concorrente: a revisão sistemática. Rev Bras Med Esport. 2010; 16(2):149-54.
  60. Agin D, Gallagher D, Wang J, Heymsfield SB, Pierson R, Kotler DP. Effects of whey protein and resistance exercise on body cell mass, muscle strenght, and quality of life in women with HIV. AIDS. 2001; (15): 2431-440.
  61. Roubenoff R, McDermott A, Weiss L, Suri K, Wood M, Bloch R, et al. Short-term progressive resistance training increases strenght and lean body mass in adults infected with human immunodeficiency vírus. AIDS. 1999;13:231-39.
  62. Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults. AIDS. 2001,15: 693-701.
  63. O’Brien K1, Nixon S, Tynan AM, Glazier R. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD001796.
  64. Sattler FR, Rajicic N, Mulligan K, Yarasheski KE, Koletar SL, Zolopa A, et al. Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial. Am J Clin Nutr. 2008;88:1313-1321.
  65. Berger B, Ollenschlager G, Schrappe M, Stute A, Fischer M, Wessel D, et al. Nutrition behavior of malnourished HIV-infected patients and intensified oral nutritional intervention. Nutrition. 1993;9:43-4.
  66. Dowling S, Mulcahy F, Gibney M. Nutrition in the management of HIV antibody positive patients: a longitudinal study of diabetic outpatient advice. Eur J Clin Nutr. 1990:44: 823-9.
  67. Oster M, Enders S, Samuels S. Megestrol acetate in patients with AIDS and caquexia. Ann Intern Med. 1994;121:400-8.
  68. Beal JA, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Sympton Manage. 1995;10:89-97.
  69. Grunfeld C, Kotler DP, Dobs A, Glesby M, Bhasin S. Oxandrolone in the treatment of HIV-associated weight loss in men. J Acquir Immune Defic Syndr 2006;41(3):304-14.
  70. Coodley GO, Coodley MK. A trial of testosterone therapy for HIV-associated weight loss. AIDS. 1997;11:1347-52.
  71. Richelsen B. Action of growth hormone in adipose tissue. Horm Res. 1997;48(5):105-10.
  72. Paton NI, Newton PJ, Sharpstone DR. Short term growth hormone administration at the time of opportunistic infections in HIV-positive patients. AIDS. 1999;13:1195-1202.
  73. Carroll PV, Christ ER, Bengston BA. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab. 1998; 83:382-95.
  74. Engelson ES, Glesby MJ, Mendez D, Albu JB, Wang J, Heymsfield SB, et al. Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection. JAIDS. 2002;30:379-91.

How to Cite

Santos, K. M. dos. (2022). Intervenções Nutrológicas em Pacientes Adultos Infectados pelo Vírus da Imunodeficiência Humana. International Journal of Nutrology, 9(1), 119–127. https://doi.org/10.1055/s-0040-1705271